Recent figures from research and consulting firm GlobalData shows that the Saudi pharmaceutical market will grow from an estimated 4.5 billion USD in 2015 to a whopping 6 billion USD by 2020. Saudi Arabia already boasts one of the largest pharma markets in the Middle East, with population growth driving increasing demand for cutting-edge, efficient healthcare solutions.
The Saudi pharma market is perhaps unique in that, in broad terms, price sensitivity and cost efficiency is not a major factor in the decision-making process of consumers. This has opened the doors for the development and distribution of pharmaceutical products that may not have expected to find similar commercial success in other markets.
Saudi Arabia’s pharmaceutical sector, and its healthcare market at large, is also notable in terms of the level of government spending on health services and social development, which stood at 20.8 billion USD in 2015.
This spending was largely concentrated on the construction of new hospitals and reference laboratories for medical centres, polyclinics and blood banks. The Saudi government aims to boost the quality of healthcare services across the Kingdom. Investment into new, innovative healthcare solutions are key to the implementation of this plan.
Saudi investors are able and willing to invest in overseas healthcare opportunities if they can be demonstrated to provide a real benefit to the national healthcare market, or support investors in their pursuit of asset diversification in the wake of the oil price crash.
Middle Eastern investors are able and willing to invest in overseas healthcare opportunities if they can be demonstrated to provide a real benefit to the regional healthcare market, or support investors in their pursuit of asset diversification in the wake of the oil price crash.
Naseba is a deal facilitator that has spent over a decade building a network of contacts with Middle Eastern investors. This network includes family offices, sovereign wealth funds, investment firms, high net worth individuals and members of royalty.
Our investor analyst team speaks to investors on a daily basis in order to fully understand their needs and mandates. The team has identified a rising trend among regional investors towards overseas healthcare investments – particularly in Europe and in emerging markets.
On October 4th, 2016, we will be organising a private investor meeting in Dubai & Riyadh to introduce pre-screened Middle Eastern investors to pre-qualified healthcare investment opportunities.
Submit your business case:
Oops! We could not locate your form.
To learn more, contact:
Naseba investor introduction
+971 4 455 7954